PEB · Pebblebrook Hotel Trust - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.48B | $1.45B | $1.42B | $1.39B | $733.04M | $442.89M |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $49.47M | $48.08M | $44.79M | $39.19M | $38.17M | $45.16M |
| Total Operating Expenses | $1.43B | $1.37B | $1.38B | $1.38B | $822.84M | $735.60M |
| D&A | - | - | - | - | - | - |
| Operating Income | $43.80M | $84.03M | $37.81M | $14.72M | ($89.79M) | ($292.71M) |
| Interest Expense | $103.33M | $112.43M | $115.66M | $99.99M | $96.63M | $104.10M |
| Income Tax | $6.29M | ($25.63M) | $655.0K | $277.0K | $61.0K | ($3.70M) |
| Net Income | ($65.81M) | ($4.24M) | ($78.02M) | ($87.17M) | ($184.86M) | ($391.73M) |
| EPS - Basic | ($0.90) | ($0.39) | ($0.93) | ($0.95) | ($1.80) | ($3.25) |
| EPS - Diluted | ($0.90) | ($0.39) | ($0.93) | ($0.95) | ($1.80) | ($3.25) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $184.19M | $206.65M | $183.75M | $41.04M | $58.52M | $124.27M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $5.35B | $5.69B | $5.82B | $6.13B | $6.26B | $6.08B |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | $2.12B | $2.25B | $2.32B | $2.39B | $2.44B | $2.28B |
| Total Liabilities | $2.79B | $2.91B | $2.97B | $3.05B | $3.10B | $2.81B |
| Stockholders' Equity | $2.47B | $2.70B | $2.76B | $3.00B | $3.16B | $3.26B |
| Retained Earnings | ($1.39B) | - | - | - | - | - |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $249.73M | $275.00M | $236.20M | $278.75M | $70.77M | ($201.78M) |
| Investing Cash Flow | $10.32M | ($92.83M) | $142.02M | ($109.39M) | ($81.57M) | $250.12M |
| Financing Cash Flow | ($281.44M) | ($158.22M) | ($236.85M) | ($209.34M) | ($33.25M) | $31.08M |
| CapEx | - | - | - | - | - | $0 |
| Free Cash Flow | - | - | - | - | - | ($201.78M) |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 3.0% | 5.8% | 2.7% | 1.1% | -12.2% | -66.1% |
| EBITDA margin | - | - | - | - | - | - |
| Net margin | -4.5% | -0.3% | -5.5% | -6.3% | -25.2% | -88.4% |
| Free cash flow margin | - | - | - | - | - | -45.6% |
| FCF / Net income | - | - | - | - | - | 0.52 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 3.4% | 3.3% | 3.2% | 2.8% | 5.2% | 10.2% |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -1.2% | -0.1% | -1.3% | -1.4% | -3.0% | -6.4% |
| Return on equity | -2.7% | -0.2% | -2.8% | -2.9% | -5.9% | -12.0% |
| Return on invested capital | 0.8% | 1.3% | 0.6% | 0.2% | -1.3% | -4.2% |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | 0.86 | 0.83 | 0.84 | 0.80 | 0.77 | 0.70 |
| Debt / Assets | 0.40 | 0.39 | 0.40 | 0.39 | 0.39 | 0.38 |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 0.4x | 0.7x | 0.3x | 0.1x | -0.9x | -2.8x |
| Equity multiplier | 2.17 | 2.11 | 2.11 | 2.05 | 1.98 | 1.87 |
| Liabilities / Assets | 0.52 | 0.51 | 0.51 | 0.50 | 0.49 | 0.46 |
| Efficiency | ||||||
| Asset turnover | 0.28 | 0.26 | 0.24 | 0.23 | 0.12 | 0.07 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | 0.5x | 0.6x | 0.7x | 0.6x | 0.9x | 0.8x |
| P / S | 0.9x | 1.1x | 1.4x | 1.3x | 4.0x | 5.5x |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 1.5% | 2.3% | 2.0% | 89.9% | 65.5% | -72.5% |
| Revenue CAGR (3y) | 2.0% | 25.6% | 47.5% | -4.8% | -3.5% | - |
| Revenue CAGR (5y) | 27.2% | -2.1% | 11.7% | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | -47.9% | 122.2% | 156.8% | - | 69.3% | - |
| Net income growth (YoY) | -1451.4% | 94.6% | 10.5% | 52.8% | 52.8% | - |
| EPS growth (YoY) | -130.8% | 58.1% | 2.1% | 47.2% | 44.6% | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -8.5% | -2.4% | -7.8% | -5.1% | -3.1% | -10.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$1.47B totalReportable Segment$1.47B · 100.0%
Product / service
$1.48B totalOccupancy$920.17M · 62.4%
Food And Beverage$388.38M · 26.3%
Hotel Other$167.00M · 11.3%
Geographic
$1.48B totalSan Diego California$330.45M · 22.4%
Boston Massachusetts$275.62M · 18.7%
Southern Florida And Georgia$266.99M · 18.1%
Los Angeles California$162.37M · 11.0%
San Francisco California$146.92M · 10.0%
Portland Oregon$78.49M · 5.3%
Chicago Illinois$78.09M · 5.3%
Other$73.01M · 4.9%
DC$63.60M · 4.3%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- -Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing Pebblebrook Hotel Trust against the 5 most active filers in the same SIC group.
Dividends
$0.04/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| Mar 31, 2026 | $0.0100 |
| Dec 31, 2025 | $0.0100 |
| Sep 30, 2025 | $0.0100 |
| Jun 30, 2025 | $0.0100 |
| Mar 31, 2025 | $0.0100 |
| Dec 31, 2024 | $0.0100 |
| Sep 30, 2024 | $0.0100 |
| Jun 28, 2024 | $0.0100 |
| Mar 27, 2024 | $0.0100 |
| Dec 28, 2023 | $0.0100 |
| Sep 28, 2023 | $0.0100 |
| Jun 29, 2023 | $0.0100 |
| Mar 30, 2023 | $0.0100 |
| Dec 29, 2022 | $0.0100 |
| Sep 29, 2022 | $0.0100 |
| Jun 29, 2022 | $0.0100 |
| Mar 30, 2022 | $0.0100 |
| Dec 30, 2021 | $0.0100 |
| Sep 29, 2021 | $0.0100 |
| Jun 29, 2021 | $0.0100 |
| Mar 30, 2021 | $0.0100 |
| Dec 30, 2020 | $0.0100 |
| Sep 29, 2020 | $0.0100 |
| Jun 29, 2020 | $0.0100 |